Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer therapy. Exhibits strong binding affinity in targeted drug designs due to its ability to interact with ATP-binding sites in enzymes. Also employed in research settings for structure-activity relationship (SAR) studies, helping optimize potency and selectivity in new drug candidates. Its structural features support improved metabolic stability and bioavailability in preclinical compounds.